Litcius/Paper detail

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Rachel Lorenc, Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna, Magdalena Corona, Ana Alarcón Tomás, Giulio Cassanello, Lori A. Leslie, Kai Rejeski, Richard J. Lin, Michael Scordo, Gunjan L. Shah, M. Lia Palomba, Gilles Salles, Jae H. Park, Sergio Giralt, Miguel‐Angel Perales, Andrew Ip, Parastoo B. Dahi

2024Transplantation and Cellular Therapy13 citationsDOIOpen Access PDF

Topics & Concepts

Chimeric antigen receptorLymphomaCD19AntigenMedicineCancer researchImmunologyVirologyImmunotherapyImmune systemCAR-T cell therapy researchLymphoma Diagnosis and Treatment
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma | Litcius